In this randomized controlled trial, oral semaglutide significantly reduced the risk of adverse cardiovascular events in ...

The sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin, widely used to treat type 2 diabetes, also shows ...

Improves fibrosis and steatohepatitis Metabolic dysfunction-associated steatotic liver disease (MASLD) encompasses a broad clinical spectrum, ranging from simple steatosis to metabolic ...

Currently, the only approved treatment for MASH on the market is the thyroid hormone receptor β agonist resmetirom (Rezdiffra ...

Hydrocortisone oral solution (Khindivi) was approved as a replacement therapy for pediatric patients ages 5 years and up with ...

Any thoughts on milk thistle supplements in fatty liver disease that was diagnosed by an ultrasound due to elevated AST and ...

Mazdutide, used in the treatment of obesity and metabolic diseases, could become the first domestically-developed dual-target ...

Drug-induced liver injury cases are increasing, with common medications and supplements posing hidden dangers, especially for ...

Ozempic may affect your face, bowel movements and hair. Check out the Ozempic side effects before taking this anti-diabetes ...

For example, liraglutide and semaglutide. For example ... as obesity is the main driver of this common liver disease and its associated metabolic comorbidities. We searched PubMed and MEDLINE to ...

Altimmune nears a key MASH trial readout, with strong market potential and new liver and alcohol studies supporting growth.